Published in

De Gruyter, Journal of Drug Policy Analysis, 2(10)

DOI: 10.1515/jdpa-2016-0008

Links

Tools

Export citation

Search in Google Scholar

Higher Regulatory Control of Tramadol to Prevent its Abuse and Dependence

Journal article published in 2017 by Sahba Jalali, Dixon Thomas, Padma Shetty, Jason C. Cooper
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Orange circle
Published version: archiving restricted
Data provided by SHERPA/RoMEO

Abstract

AbstractTramadol abuse potential is not well studied. While some studies claim low abuse potential, others signal significant public health risks associated with tramadol abuse. This is a review on the abuse and dependence potential of tramadol. Tramadol was originally approved as non-controlled drug, but there is a trend to recognize tramadol as a controlled substance by regulators in many countries. Several factors contribute to abuse of tramadol. The leading reasons include history of drug abuse, geographical variation, and lessened regulatory controls. Tramadol abuse can cause increases in seizures and suicidal ideations. Abusers experience withdrawal symptoms and worsening of depression. Higher regulatory control of tramadol is warranted to avoid its misuse.